Cerebral acquires Inflow

Cerebral, a San Francisco-based telemental health company, has acquired Inflow, a care management app, for $3.6 million. This acquisition marks Cerebral's reentry into the Attention Deficit Hyperactivity Disorder (ADHD) care sector. The move is part of the company's broader strategy to expand its insurance-based care offerings under a new strategic direction known as “Cerebral 2.0.”

Cerebral has been eyeing acquisition opportunities since achieving a $4.8 billion valuation in 2021 following its Series C fundraising. However, it wasn't until August 2025 that Cerebral initiated its acquisition efforts, starting with New York City-based Resilience Labs, which offers therapy and medication management services. The Inflow deal represents only the second acquisition for Cerebral. CEO Brian Reinken emphasizes that although Cerebral has continued to serve ADHD patients, the acquisition of Inflow allows for a more robust offering by enhancing self-guided and self-care support tools available to its user base.

The acquisition provides Cerebral with the means to furnish its therapists with additional tools that facilitate an expanded range of patient care options. Reinken highlights the significant untreated population of adults with ADHD, affirming that integrating Inflow's features can significantly bolster Cerebral's service platform without altering the company’s existing prescription policies. Notably, Cerebral had settled with the Department of Justice in late 2024 over allegations regarding prescriptions of controlled substances, agreeing to avoid these prescriptions in the future.

Inflow, which had previously raised financing in a Series A round, now positions itself to grow beyond its initial capabilities. The app previously focused on care support but now seeks to enhance its clinical infrastructure. Levi Epstein, CEO and co-founder of Inflow, acknowledges the partnership with Cerebral as a step toward achieving a shared vision of continuous care and an improved infrastructure to support patients comprehensively.

While Inflow will maintain operational independence for the short term, the relationship allows for re-evaluation of how integration might evolve. This move comes amid increases in ADHD awareness and diagnoses, signifying a shift in the competitive landscape. Companies within the behavioral health sector may seek to similarly enhance their platforms by integrating digital health tools to offer more comprehensive patient care solutions. Looking forward, any further integration between the companies and adjustments to Cerebral's care approach will be assessed in alignment with patient needs and market dynamics.